A detailed history of Geode Capital Management, LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 768,566 shares of ACET stock, worth $737,823. This represents 0.0% of its overall portfolio holdings.

Number of Shares
768,566
Previous 670,999 14.54%
Holding current value
$737,823
Previous $811,000 36.37%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.07 - $1.63 $104,396 - $159,034
97,567 Added 14.54%
768,566 $1.11 Million
Q2 2024

Aug 09, 2024

SELL
$1.21 - $2.4 $646,094 - $1.28 Million
-533,962 Reduced 44.31%
670,999 $811,000
Q1 2024

May 13, 2024

BUY
$1.76 - $3.45 $955,972 - $1.87 Million
543,166 Added 82.07%
1,204,961 $2.83 Million
Q4 2023

Feb 13, 2024

BUY
$1.11 - $1.89 $32,013 - $54,509
28,841 Added 4.56%
661,795 $1.25 Million
Q3 2023

Nov 13, 2023

SELL
$1.37 - $3.4 $20 - $51
-15 Reduced -0.0%
632,954 $867,000
Q2 2023

Aug 11, 2023

BUY
$2.13 - $7.13 $57,041 - $190,941
26,780 Added 4.42%
632,969 $1.54 Million
Q1 2023

May 15, 2023

BUY
$5.52 - $9.23 $88,502 - $147,984
16,033 Added 2.72%
606,189 $3.49 Million
Q4 2022

Feb 13, 2023

BUY
$7.72 - $21.27 $398,822 - $1.1 Million
51,661 Added 9.59%
590,156 $5.28 Million
Q3 2022

Nov 14, 2022

BUY
$13.43 - $18.74 $1.57 Million - $2.19 Million
116,927 Added 27.74%
538,495 $7.66 Million
Q2 2022

Aug 12, 2022

BUY
$10.26 - $20.81 $305,060 - $618,743
29,733 Added 7.59%
421,568 $6.15 Million
Q1 2022

May 13, 2022

BUY
$11.53 - $19.97 $960,610 - $1.66 Million
83,314 Added 27.0%
391,835 $7.82 Million
Q4 2021

Feb 11, 2022

SELL
$7.37 - $17.49 $227,283 - $539,374
-30,839 Reduced 9.09%
308,521 $5.4 Million
Q3 2021

Nov 12, 2021

BUY
$6.29 - $9.93 $132,209 - $208,718
21,019 Added 6.6%
339,360 $2.66 Million
Q2 2021

Aug 13, 2021

BUY
$9.19 - $15.93 $1.83 Million - $3.17 Million
199,026 Added 166.81%
318,341 $3.28 Million
Q1 2021

May 12, 2021

BUY
$12.12 - $17.17 $1.04 Million - $1.47 Million
85,839 Added 256.42%
119,315 $1.56 Million
Q4 2020

Feb 12, 2021

BUY
$10.36 - $14.77 $48,225 - $68,754
4,655 Added 16.15%
33,476 $470,000
Q3 2020

Nov 13, 2020

BUY
$10.18 - $21.4 $293,397 - $616,769
28,821 New
28,821 $342,000

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $38.4M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.